Attached files

file filename
8-K - FORM 8-K - KINDRED HEALTHCARE, INCd493145d8k.htm

EXHIBIT 99.1

 

LOGO

 

Contact: Richard A. Lechleiter

Executive Vice President and

Chief Financial Officer

(502) 596-7734

KINDRED HEALTHCARE ANNOUNCES FOURTH QUARTER RESULTS

 

 

Excluding Certain Items, Company Reports Fourth Quarter Continuing Operations

Diluted EPS of $0.46 Compared to $0.28 in 2011

Company Reports GAAP Continuing Operations Loss of $1.56 per Diluted Share in the Fourth Quarter

Resulting Primarily from a Goodwill Impairment Charge

Annual Operating Cash Flows in Excess of Routine and Development Capital Spending Totaled $97 Million

 

 

Company Maintains Fiscal 2013 Core Earnings Guidance of $1.10 to $1.30

LOUISVILLE, Ky. (February 25, 2013) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced its operating results for the fourth quarter and year ended December 31, 2012. The Company’s consolidated financial statements include the operating results of RehabCare Group, Inc. (“RehabCare”) since the closing of the acquisition on June 1, 2011. All financial and statistical information included in this press release reflects the continuing operations of the Company’s businesses for all periods presented unless otherwise indicated.

Operating and Financial Highlights:

 

   

Fourth quarter consolidated revenues grew 2%

 

  Hospital and home health combined for revenue gains of 6% compared to last year

 

   

Hospital division posted solid fourth quarter results

 

  Fourth quarter revenues grew 3% and operating income rose 8%

 

  While overall admissions were soft, same store non-government admissions rose 2% compared to last year

 

   

RehabCare division fourth quarter revenues grew 1% while operating income climbed 53%

 

  Operating results were bolstered by 27% growth in hospital-based rehabilitation services as well as strong cash collections and a related $8 million bad debt benefit

 

  New Medicare Part B therapy caps reduced skilled rehabilitation therapy operating income by approximately $6 million in the quarter

 

   

Fourth quarter home health and hospice division revenues and operating income nearly doubled from last year

 

  Annualized revenues reach $200 million

 

  Home health and hospice operations now reside in 12 of 21 Kindred integrated care markets

 

   

Company posted strong full-year cash flows in 2012

 

  Operating cash flows less routine and development capital spending totaled $97 million

 

   

Company maintains strong financial position entering 2013

 

  Cash flows in excess of routine and development capital spending in 2013 should approximate $90 million

 

  Available credit capacity approximated $420 million at December 31, 2012

680 South Fourth Street    Louisville, Kentucky 40202

502.596.7300    www.kindredhealthcare.com

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 2

February 25, 2013

 

Fourth Quarter Results

Continuing Operations

Consolidated revenues for the fourth quarter ended December 31, 2012 increased 2% to $1.55 billion compared to $1.52 billion in the same period in 2011. The Company reported a loss from continuing operations for the fourth quarter of 2012 of $80.7 million or $1.56 per diluted share compared to a loss of $65.5 million or $1.28 per diluted share in the fourth quarter of 2011. Operating results for the fourth quarter of 2012 included (a) an asset impairment charge, (b) severance and restructuring costs, (c) transaction-related costs and (d) employee retention costs associated with the upcoming disposal of 54 nursing centers leased from Ventas, Inc. (“Ventas”) (NYSE:VTR) that reduced income from continuing operations by $105.3 million or $2.04 per diluted share. Operating results for the fourth quarter of 2011 included asset impairment charges, transaction-related costs and a loss on a hospital divestiture that reduced income from continuing operations by $79.9 million or $1.56 per diluted share.

During the fourth quarter of 2012, the Company recorded a $108 million goodwill impairment charge to reflect circumstances in which the carrying value of certain assets exceeded their fair value. The impairment charge resulted primarily from the expected decline in operating results in the Company’s rehabilitation division related to previously announced Medicare reimbursement changes that were recently enacted by Congress in connection with the American Taxpayer Relief Act of 2012 (the “Taxpayer Relief Act”).

Fiscal Year Results

Continuing Operations

Consolidated revenues for the year ended December 31, 2012 increased 12% to $6.2 billion compared to $5.5 billion in the previous year. The Company reported a loss from continuing operations of $33.4 million or $0.65 per diluted share in 2012 compared to a loss of $47.8 million or $1.04 per diluted share in 2011.

In addition to the charges noted above in the discussion of fourth quarter results, operating results in 2012 included (a) costs incurred in connection with the closing of a regional office, (b) lease cancellation charges and other costs incurred in connection with two hospital closings and the cancellation of a sub-acute unit project and (c) a charge in connection with an employment-related lawsuit, all of which reduced income from continuing operations by $114.1 million or $2.21 per diluted share. Operating results in 2011 included certain items that reduced income from continuing operations by $134.3 million or $2.90 per diluted share, most of which were related to asset impairment charges and the RehabCare acquisition.

Discontinued Operations

During 2012, the Company entered into transactions related to the divestiture of unprofitable businesses qualifying as discontinued operations. For accounting purposes, the historical operating results and losses on the disposal of these businesses have been classified as discontinued operations in the Company’s consolidated statement of operations for all historical periods.

The Company will account for the divestiture of 54 nursing centers leased from Ventas as discontinued operations in 2013.

Management Commentary

Paul J. Diaz, Kindred’s Chief Executive Officer, commented, “In 2012, Kindred continued to make progress in improving quality and patient satisfaction and delivering better clinical outcomes for patients in settings across the post-acute continuum. We want to thank our care givers and colleagues throughout our organization who delivered on Kindred’s promise of hope, healing and recovery, as they worked to advance our mission in spite of a very challenging operating environment.”

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 3

February 25, 2013

 

Commenting on the Company’s recently issued 2012 Quality and Social Responsibility Report, Mr. Diaz noted, “Kindred is proud to issue its sixth annual Quality and Social Responsibility Report to fulfill our commitment to be transparent about our quality results and our ongoing efforts to improve the care and services for our patients and residents.” Mr. Diaz also noted that the report links the Company’s quality initiatives with its Continue the Care and integrated care market strategies. “Both policymakers and the marketplace are demanding that healthcare providers participate in coordinated care strategies to improve care transitions, reduce avoidable hospitalizations and lower costs. Kindred’s integrated care market strategy is designed to leverage Kindred’s national scale to build a continuum of post-acute services in local healthcare delivery markets to achieve these shared goals. Kindred is aggressively developing a post-acute continuum of service lines in local markets, including transitional care hospitals, inpatient rehabilitation facilities, sub-acute or transitional care, and home health and hospice services, in order to partner with physician groups, hospitals, health systems and payors to better manage episodes of care while at the same time improving quality and lowering costs.”

Mr. Diaz remarked, “From an operational standpoint, we finished the year with a solid quarter. Excluding certain items, our continuing operations earnings per diluted share of $0.46 in the fourth quarter was a significant improvement from the comparable $0.28 per share reported last year following major Medicare cuts in both our nursing center and rehabilitation therapy divisions.”

Mr. Diaz further noted, “For the full year, we are pleased to report that we met our core earnings objectives that we estimated at the beginning of the year. Our hospital results were solid, we maintained stability in our nursing center division, our rehabilitation therapy division made great progress in the midst of several Medicare reimbursement changes and we doubled the size of our home health and hospice business. I would characterize 2012 as solid year for Kindred as we met or exceeded most of our clinical and financial goals.”

Commenting on the Company’s strategic initiatives, Mr. Diaz noted, “In 2012, we continued to grow and enhance our integrated care market capabilities, particularly in home health and hospice services, while advancing a strategy to reposition our business mix with the goal of improving our long-term growth, profitability and financial position. Specifically, we completed three home health and hospice acquisitions that added $75 million of annualized revenues and we acquired three previously leased facilities for approximately $103 million that will benefit our balance sheet leverage over time. We also continued to move forward with the divestiture of 54 nursing centers leased from Ventas. In addition, our process to divest other non-strategic assets continues and will result in further changes to our business mix over the course of 2013 and beyond. We also continue to evaluate our active pipeline of acquisition opportunities in our integrated care markets in an effort to advance our strategy, strengthen the Company and enhance shareholder value going forward.”

Mr. Diaz added, “Our significant operating cash flows in excess of routine and development capital spending, as well as our $420 million of available credit going into 2013, provide the financial strength to further reposition the Company’s business mix and advance our Continue the Care strategy in our integrated care markets.”

Looking forward to 2013, Mr. Diaz remarked, “The volume momentum that we saw in December has carried over nicely into our first quarter. Based on our January results, we believe that the new year is off to a strong start.”

Earnings Guidance – Continuing Operations

The Company maintained its previous earnings guidance for 2013. The Company expects consolidated revenues for 2013 to approximate $5.9 billion. Operating income, or earnings before interest, income taxes, depreciation, amortization and rent, is expected to range from $794 million to $810 million. Rent expense is expected to approximate $387 million, while depreciation and amortization should approximate $189 million. Net interest expense is expected to approximate $113 million. The Company expects to report income from continuing operations for 2013 between $60 million and $70 million or $1.10 to $1.30 per diluted share (based upon diluted shares of 52.7 million).

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 4

February 25, 2013

 

The Company re-affirmed its operating cash flow guidance for 2013 at a range between $230 million and $250 million. Estimated routine capital expenditures for 2013 are expected to range from $120 million to $130 million. In addition to its routine capital expenditures, the Company re-affirmed that its development of new or replacement transitional care (“TC”) hospitals, transitional care centers, and inpatient rehabilitation hospitals (“IRFs”) will approximate $20 million to $30 million in 2013. Operating cash flows in excess of the Company’s routine and development capital spending programs, which are expected to approximate $90 million for 2013, will be available to repay debt and fund acquisitions.

The Company’s earnings guidance for 2013 assumes (a) reductions in Medicare payments for rehabilitation therapy services, including those contained in the Taxpayer Relief Act, expected to range from $25 million to $30 million on an annual basis, and (b) sequestration cuts of 2% related to all of its Medicare revenues that will begin on April 1, 2013. In addition, the guidance assumes that the previously announced exit in 2013 from 54 nursing centers leased from Ventas will be reflected as discontinued operations effective January 1, 2013. The earnings guidance also excludes the effect of any other reimbursement changes, any future acquisitions or dispositions, any impairment charges, and any repurchases of common stock.

In light of the significant reimbursement pressures in 2012, and the expected further reimbursement reductions that are projected to aggregate approximately $100 million in 2013, the Company has focused its efforts on reducing costs and streamlining its operations across the enterprise without impacting the quality of its services. These initiatives have been pursued under the direction of an internal project management team commonly referred to as Project Apollo. Among other things, Project Apollo is driving various structural changes in human resources, sales, marketing and finance under a shared service model that more efficiently meets the needs of the Company’s four major operating divisions. Other areas of emphasis include a re-design of the Company’s employee health plan (including the introduction of higher deductible plans complimented by Company-funded health savings accounts) as well as certain refinements to employee compensation using a market-based total rewards program.

Project Apollo is expected to result in $60 million to $70 million of cost savings in 2013, with a fully implemented annual impact of more than $90 million in 2014.

In the context of Project Apollo, the Company recently initiated a pay freeze across the enterprise and is pursuing certain other cost reductions in 2013. However, in an effort to remain competitive in the marketplace (without increasing its structural costs), the Company will pay a one-time bonus to approximately 47,000 employees who do not participate in the Company’s incentive compensation program. The aggregate pretax cost of this one-time item is expected to approximate $25 million and is not included in the Company’s annual 2013 earnings guidance.

While the Company does not provide quarterly earnings guidance, investors are advised that the Company’s new employee health plan for 2013 requires that a larger portion of the Company’s costs be funded in the first quarter of the year. While the Company expects its aggregate employee health costs for the full year to be flat with 2012 levels, first quarter 2013 costs will be approximately $8 million higher than the same period last year and the subsequent three fiscal quarters will, in aggregate, be lower in costs by the same amount.

Conference Call

As previously announced, investors and the general public may access a live webcast of the fourth quarter 2012 conference call through a link on the Company’s website at http://investors.kindredhealthcare.com or at www.earnings.com. The conference call will be held February 26 at 9:00 a.m. (Eastern Time).

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 5

February 25, 2013

 

A telephone replay of the conference call will become available at approximately 12:00 p.m. on February 26 by dialing 888-203-1112, access code: 9258742. The replay will be available through March 8.

As previously announced, Mr. Diaz will make a presentation regarding the Company at the Citi Global Healthcare Conference in New York City on Tuesday, February 26, 2013, at 2:15 p.m. Eastern Time. He will also take part in a discussion with Frank G. Morgan, CFA, Managing Director, Equity Research: Healthcare Services, at the RBC Capital Markets Healthcare Conference in New York City on Wednesday, February 27, 2013, at 2:30 p.m. (Eastern Time).

In addition, Benjamin A. Breier, President and Chief Operating Officer, will make a presentation regarding the Company at the J.P. Morgan Global High Yield and Leveraged Finance Conference in Miami, Florida, on Wednesday, February 27, 2013, at 11:00 a.m. (Eastern Time).

An updated investor presentation will be available on the Company’s website prior to these meetings.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.

Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based upon management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

In addition to the factors set forth above, other factors that may affect the Company’s plans, results or stock price include, without limitation, (a) the impact of healthcare reform, which will initiate significant changes to the United States healthcare system, including potential material changes to the delivery of healthcare services and the reimbursement paid for such services by the government or other third party payors, including reforms resulting from the Patient Protection and Affordable Care Act and the Healthcare Education and Reconciliation Act (collectively, the “ACA”) or future deficit reduction measures adopted at the federal or state level. Healthcare reform is affecting each of the Company’s businesses in some manner. Potential future efforts in the U.S. Congress to repeal, amend, modify or retract funding for various aspects of the ACA create additional uncertainty about the ultimate impact of the ACA on the Company and the healthcare industry. Due to the substantial regulatory changes that will need to be implemented by the Centers for Medicare and Medicaid Services (“CMS”) and others, and the numerous processes required to implement these reforms, the Company cannot predict which healthcare initiatives will be implemented at the federal or state level, the timing of any such reforms, or the effect such reforms or any other future legislation or regulation will have on the Company’s business, financial position, results of operations and liquidity, (b) the impact of final rules issued by CMS on August 1, 2012 which, among other things, will reduce Medicare reimbursement to the Company’s TC hospitals in 2013 and beyond by imposing a budget neutrality adjustment and modifying the short-stay outlier rules, (c) the impact of final rules issued by CMS on July 29, 2011 which significantly reduced Medicare reimbursement to the Company’s nursing centers and changed payments for the provision of group therapy services

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 6

February 25, 2013

 

effective October 1, 2011, (d) the impact of the Budget Control Act of 2011 (as amended by the Taxpayer Relief Act) which will automatically reduce federal spending by approximately $1.2 trillion split evenly between domestic and defense spending. At this time, the Company believes that the automatic 2% reduction on each claim submitted to Medicare will begin on April 1, 2013, (e) the impact of the Taxpayer Relief Act which, among other things, reduces Medicare payments by 50% for subsequent procedures when multiple therapy services are provided on the same day. At this time, the Company believes that the new rules related to multiple therapy services will reduce the Company’s Medicare revenues by $25 million to $30 million on an annual basis, (f) changes in the reimbursement rates or the methods or timing of payment from third party payors, including commercial payors and the Medicare and Medicaid programs, changes arising from and related to the Medicare prospective payment system for long-term acute care (“LTAC”) hospitals, including potential changes in the Medicare payment rules, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, and changes in Medicare and Medicaid reimbursement for the Company’s TC hospitals, nursing centers, IRFs and home health and hospice operations, and the expiration of the Medicare Part B therapy cap exception process, (g) the effects of additional legislative changes and government regulations, interpretation of regulations and changes in the nature and enforcement of regulations governing the healthcare industry, (h) the ability of the Company’s hospitals to adjust to potential LTAC certification and medical necessity reviews, (i) the impact of the Company’s significantly increased levels of indebtedness as a result of the RehabCare acquisition on the Company’s funding costs, operating flexibility and ability to fund ongoing operations, development capital expenditures or other strategic acquisitions with additional borrowings, (j) the Company’s ability to successfully pursue its development activities, including through acquisitions, and successfully integrate new operations, including the realization of anticipated revenues, economies of scale, cost savings and productivity gains associated with such operations, as and when planned, including the potential impact of unanticipated issues, expenses and liabilities associated with those activities, (k) the failure of the Company’s facilities to meet applicable licensure and certification requirements, (l) the further consolidation and cost containment efforts of managed care organizations and other third party payors, (m) the Company’s ability to meet its rental and debt service obligations, (n) the Company’s ability to operate pursuant to the terms of its debt obligations, and comply with its covenants thereunder, and its ability to operate pursuant to its master lease agreements with Ventas, (o) the condition of the financial markets, including volatility and weakness in the equity, capital and credit markets, which could limit the availability and terms of debt and equity financing sources to fund the requirements of the Company’s businesses, or which could negatively impact the Company’s investment portfolio, (p) national and regional economic, financial, business and political conditions, including their effect on the availability and cost of labor, credit, materials and other services, (q) the Company’s ability to control costs, particularly labor and employee benefit costs, (r) increased operating costs due to shortages in qualified nurses, therapists and other healthcare personnel, (s) the Company’s ability to attract and retain key executives and other healthcare personnel, (t) the increase in the costs of defending and insuring against alleged professional liability and other claims and the Company’s ability to predict the estimated costs related to such claims, including the impact of differences in actuarial assumptions and estimates compared to eventual outcomes, (u) the Company’s ability to successfully reduce (by divestiture of operations or otherwise) its exposure to professional liability and other claims, (v) the Company’s ability to successfully dispose of unprofitable facilities, (w) events or circumstances which could result in the impairment of an asset or other charges, such as the impact of Medicare reimbursement regulations that resulted in the Company recording significant impairment charges in 2012 and 2011, (x) changes in generally accepted accounting principles (“GAAP”) or practices, and changes in tax accounting or tax laws (or authoritative interpretations relating to any of these matters), and (y) the Company’s ability to maintain an effective system of internal control over financial reporting. Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 7

February 25, 2013

 

In addition to the results provided in accordance with GAAP, the Company has provided information in this release to compute certain non-GAAP measurements for the fourth quarter and years ended December 31, 2012 and 2011 before certain charges or on a core basis. A reconciliation of the non-GAAP measurements to the GAAP measurements is included in this press release.

As noted above, the Company’s earnings release includes a financial measure referred to as operating income, or earnings before interest, income taxes, depreciation, amortization and rent. The Company’s management uses operating income as a meaningful measure of operational performance in addition to other measures. The Company uses operating income to assess the relative performance of its operating divisions as well as the employees that operate these businesses. In addition, the Company believes this measurement is important because securities analysts and investors use this measurement to compare the Company’s performance to other companies in the healthcare industry. The Company believes that income (loss) from continuing operations is the most comparable GAAP measure. Readers of the Company’s financial information should consider income (loss) from continuing operations as an important measure of the Company’s financial performance because it provides the most complete measure of its performance. Operating income should be considered in addition to, not as a substitute for, or superior to, financial measures based upon GAAP as an indicator of operating performance. A reconciliation of operating income to income (loss) from continuing operations provided in the Condensed Business Segment Data is included in this press release.

About Kindred Healthcare

Kindred Healthcare, Inc., a top-125 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville, Kentucky with annual revenues of $6 billion and approximately 78,000 employees in 46 states. At December 31, 2012, Kindred through its subsidiaries provided healthcare services in 2,203 locations, including 116 transitional care hospitals, six inpatient rehabilitation hospitals, 223 nursing centers, 27 sub-acute units, 101 hospice, home care and private duty locations, 105 inpatient rehabilitation units (hospital-based) and a contract rehabilitation services business, RehabCare, which served 1,625 non-affiliated facilities. Ranked as one of Fortune magazine’s Most Admired Healthcare Companies for four years in a row, Kindred’s mission is to promote healing, provide hope, preserve dignity and produce value for each patient, resident, family member, customer, employee and shareholder we serve. For more information, go to www.kindredhealthcare.com.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 8

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Financial Summary

(In thousands, except per share amounts)

 

     Three months ended     Year ended  
     December 31,     December 31,  
     2012     2011     2012     2011  

Revenues

   $ 1,547,721      $ 1,517,435      $ 6,181,291      $ 5,503,928   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from continuing operations

   $ (79,892   $ (65,534   $ (32,371   $ (48,053

Discontinued operations, net of income taxes:

        

Loss from operations

     (5     (6,355     (2,208     (5,666

Loss on divestiture of operations

     (939     —          (4,745     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from discontinued operations

     (944     (6,355     (6,953     (5,666
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (80,836     (71,889     (39,324     (53,719

(Earnings) loss attributable to noncontrolling interests

     (790     58        (1,043     238   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss attributable to Kindred

   $ (81,626   $ (71,831   $ (40,367   $ (53,481
  

 

 

   

 

 

   

 

 

   

 

 

 

Amounts attributable to Kindred stockholders:

        

Loss from continuing operations

   $ (80,682   $ (65,476   $ (33,414   $ (47,815

Loss from discontinued operations

     (944     (6,355     (6,953     (5,666
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (81,626   $ (71,831   $ (40,367   $ (53,481
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss per common share:

        

Basic:

        

Loss from continuing operations

   $ (1.56   $ (1.28   $ (0.65   $ (1.04

Discontinued operations:

        

Loss from operations

     —          (0.12     (0.04     (0.12

Loss on divestiture of operations

     (0.02     —          (0.09     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (1.58   $ (1.40   $ (0.78   $ (1.16
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted:

        

Loss from continuing operations

   $ (1.56   $ (1.28   $ (0.65   $ (1.04

Discontinued operations:

        

Loss from operations

     —          (0.12     (0.04     (0.12

Loss on divestiture of operations

     (0.02     —          (0.09     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (1.58   $ (1.40   $ (0.78   $ (1.16
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing loss per common share:

        

Basic

     51,692        51,335        51,659        46,280   

Diluted

     51,692        51,335        51,659        46,280   

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 9

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Operations

(In thousands, except per share amounts)

 

     Three months ended     Year ended  
     December 31,     December 31,  
     2012     2011     2012     2011  

Revenues

   $ 1,547,721      $ 1,517,435      $ 6,181,291      $ 5,503,928   
  

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

     914,171        907,853        3,672,475        3,243,603   

Supplies

     107,125        107,043        432,008        399,819   

Rent

     107,737        106,135        428,979        398,045   

Other operating expenses

     306,113        311,333        1,233,134        1,160,293   

Other income

     (2,591     (2,711     (10,812     (11,191

Impairment charges

     108,952        91,490        110,856        118,202   

Depreciation and amortization

     52,353        48,101        201,068        165,227   

Interest expense

     27,934        26,244        107,896        80,919   

Investment income

     (258     (242     (1,054     (1,031
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,621,536        1,595,246        6,174,550        5,553,886   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (73,815     (77,811     6,741        (49,958

Provision (benefit) for income taxes

     6,077        (12,277     39,112        (1,905
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from continuing operations

     (79,892     (65,534     (32,371     (48,053

Discontinued operations, net of income taxes:

        

Loss from operations

     (5     (6,355     (2,208     (5,666

Loss on divestiture of operations

     (939     —          (4,745     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from discontinued operations

     (944     (6,355     (6,953     (5,666
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (80,836     (71,889     (39,324     (53,719

(Earnings) loss attributable to noncontrolling interests

     (790     58        (1,043     238   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss attributable to Kindred

   $ (81,626   $ (71,831   $ (40,367   $ (53,481
  

 

 

   

 

 

   

 

 

   

 

 

 

Amounts attributable to Kindred stockholders:

        

Loss from continuing operations

   $ (80,682   $ (65,476   $ (33,414   $ (47,815

Loss from discontinued operations

     (944     (6,355     (6,953     (5,666
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (81,626   $ (71,831   $ (40,367   $ (53,481
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss per common share:

        

Basic:

        

Loss from continuing operations

   $ (1.56   $ (1.28   $ (0.65   $ (1.04

Discontinued operations:

        

Loss from operations

     —          (0.12     (0.04     (0.12

Loss on divestiture of operations

     (0.02     —          (0.09     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (1.58   $ (1.40   $ (0.78   $ (1.16
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted:

        

Loss from continuing operations

   $ (1.56   $ (1.28   $ (0.65   $ (1.04

Discontinued operations:

        

Loss from operations

     —          (0.12     (0.04     (0.12

Loss on divestiture of operations

     (0.02     —          (0.09     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (1.58   $ (1.40   $ (0.78   $ (1.16
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing loss per common share:

        

Basic

     51,692        51,335        51,659        46,280   

Diluted

     51,692        51,335        51,659        46,280   

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 10

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Balance Sheet

(In thousands, except per share amounts)

 

     December 31,     December 31,  
     2012     2011  
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 50,007      $ 41,561   

Cash—restricted

     5,197        5,551   

Insurance subsidiary investments

     86,168        70,425   

Accounts receivable less allowance for loss

     1,038,605        994,700   

Inventories

     32,021        31,060   

Deferred tax assets

     12,663        17,785   

Income taxes

     13,573        39,513   

Other

     35,532        32,687   
  

 

 

   

 

 

 
     1,273,766        1,233,282   

Property and equipment

     2,226,903        1,975,063   

Accumulated depreciation

     (1,083,777     (916,022
  

 

 

   

 

 

 
     1,143,126        1,059,041   

Goodwill

     1,041,266        1,084,655   

Intangible assets less accumulated amortization

     439,767        447,207   

Assets held for sale

     4,131        5,612   

Insurance subsidiary investments

     116,424        110,227   

Other

     219,466        198,469   
  

 

 

   

 

 

 

Total assets

   $ 4,237,946      $ 4,138,493   
  

 

 

   

 

 

 
LIABILITIES AND EQUITY     

Current liabilities:

    

Accounts payable

   $ 210,668      $ 216,801   

Salaries, wages and other compensation

     389,009        407,493   

Due to third party payors

     35,420        37,306   

Professional liability risks

     54,088        46,010   

Other accrued liabilities

     137,204        130,693   

Long-term debt due within one year

     8,942        10,620   
  

 

 

   

 

 

 
     835,331        848,923   

Long-term debt

     1,648,706        1,531,882   

Professional liability risks

     236,630        217,717   

Deferred tax liabilities

     9,764        17,955   

Deferred credits and other liabilities

     214,671        191,771   

Noncontrolling interests-redeemable

     —          9,704   

Equity:

    

Stockholders’ equity:

    

Common stock, $0.25 par value; authorized 175,000 shares; issued 53,280 shares—December 31, 2012 and 52,116 shares—December 31, 2011

     13,320        13,029   

Capital in excess of par value

     1,145,922        1,138,189   

Accumulated other comprehensive loss

     (1,882     (1,469

Retained earnings

     98,799        139,172   
  

 

 

   

 

 

 
     1,256,159        1,288,921   

Noncontrolling interests-nonredeemable

     36,685        31,620   
  

 

 

   

 

 

 

Total equity

     1,292,844        1,320,541   
  

 

 

   

 

 

 

Total liabilities and equity

   $ 4,237,946      $ 4,138,493   
  

 

 

   

 

 

 

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 11

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Cash Flows

(In thousands)

 

     Three months ended     Year ended  
     December 31,     December 31,  
     2012     2011     2012     2011  

Cash flows from operating activities:

        

Net loss

   $ (80,836   $ (71,889   $ (39,324   $ (53,719

Adjustments to reconcile net loss to net cash provided by operating activities:

        

Depreciation and amortization

     52,392        48,227        201,484        165,594   

Amortization of stock-based compensation costs

     2,841        3,208        10,852        12,819   

Amortization of deferred financing costs

     2,592        2,350        9,683        7,581   

Payment of lender fees related to debt issuance

     (2,940     —          (2,940     (46,232

Provision for doubtful accounts

     1,038        13,084        23,692        35,133   

Deferred income taxes

     6,616        5,170        (11,524     195   

Impairment charges

     108,952        102,569        110,856        129,281   

Loss on divestiture of discontinued operations

     939        —          4,745        —     

Other

     (981     1,703        1,772        (2,063

Change in operating assets and liabilities:

        

Accounts receivable

     9,208        (36,758     (58,705     (144,830

Inventories and other assets

     (8,485     (4,451     (29,382     (802

Accounts payable

     737        299        (6,515     685   

Income taxes

     (9,294     (25,537     29,991        (4,745

Due to third party payors

     (4,411     (4,130     (2,723     568   

Other accrued liabilities

     (6,893     2,055        20,600        54,241   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     71,475        35,900        262,562        153,706   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

        

Routine capital expenditures

     (38,371     (37,640     (115,175     (132,903

Development capital expenditures

     (12,147     (18,085     (50,322     (87,655

Acquisitions, net of cash acquired

     (38,904     (4,551     (178,212     (715,458

Sale of assets

     150        —          1,260        1,714   

Purchase of insurance subsidiary investments

     (7,151     (9,719     (38,041     (35,623

Sale of insurance subsidiary investments

     8,290        8,720        38,363        46,307   

Net change in insurance subsidiary cash and cash equivalents

     (6,114     (9,343     (21,285     (14,213

Change in other investments

     11        3        1,465        1,003   

Other

     490        180        (539     (512
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (93,746     (70,435     (362,486     (937,340
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

        

Proceeds from borrowings under revolving credit

     455,000        493,500        1,784,300        2,126,800   

Repayment of borrowings under revolving credit

     (512,200     (448,500     (1,757,100     (2,198,300

Proceeds from issuance of senior unsecured notes

     —          —          —          550,000   

Proceeds from issuance of term loan, net of discount

     97,500        —          97,500        693,000   

Repayment of other long-term debt

     (2,688     (2,645     (10,664     (350,878

Payment of deferred financing costs

     (864     (383     (1,465     (9,098

Contribution made by noncontrolling interest

     —          —          200        —     

Distribution made to noncontrolling interests

     (308     —          (3,829     —     

Purchase of noncontrolling interests

     (4     —          (719     (7,292

Issuance of common stock

     147        —          147        3,019   

Other

     —          29        —          776   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     36,583        42,001        108,370        808,027   
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in cash and cash equivalents

     14,312        7,466        8,446        24,393   

Cash and cash equivalents at beginning of period

     35,695        34,095        41,561        17,168   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 50,007      $ 41,561      $ 50,007      $ 41,561   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 12

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Operations

(In thousands, except per share amounts)

 

    2011 Quarters           2012 Quarters        
    First     Second     Third     Fourth     Year     First     Second     Third     Fourth     Year  

Revenues

  $ 1,189,851      $ 1,288,478      $ 1,508,164      $ 1,517,435      $ 5,503,928      $ 1,576,359      $ 1,533,235      $ 1,523,976      $ 1,547,721      $ 6,181,291   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    676,757        762,375        896,618        907,853        3,243,603        941,939        905,037        911,328        914,171        3,672,475   

Supplies

    89,753        96,274        106,749        107,043        399,819        110,729        107,783        106,371        107,125        432,008   

Rent

    91,216        95,489        105,205        106,135        398,045        105,872        107,053        108,317        107,737        428,979   

Other operating expenses

    258,641        286,142        304,177        311,333        1,160,293        309,678        311,940        305,403        306,113        1,233,134   

Other income

    (2,785     (2,880     (2,815     (2,711     (11,191     (2,748     (2,698     (2,775     (2,591     (10,812

Impairment charges

    —          —          26,712        91,490        118,202        867        329        708        108,952        110,856   

Depreciation and amortization

    32,496        37,816        46,814        48,101        165,227        48,434        49,742        50,539        52,353        201,068   

Interest expense

    5,728        23,157        25,790        26,244        80,919        26,578        26,716        26,668        27,934        107,896   

Investment income

    (495     (257     (37     (242     (1,031     (292     (275     (229     (258     (1,054
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    1,151,311        1,298,116        1,509,213        1,595,246        5,553,886        1,541,057        1,505,627        1,506,330        1,621,536        6,174,550   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

    38,540        (9,638     (1,049     (77,811     (49,958     35,302        27,608        17,646        (73,815     6,741   

Provision (benefit) for income taxes

    15,861        (3,295     (2,194     (12,277     (1,905     14,347        11,392        7,296        6,077        39,112   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations

    22,679        (6,343     1,145        (65,534     (48,053     20,955        16,216        10,350        (79,892     (32,371

Discontinued operations, net of income taxes:

                   

Income (loss) from operations

    (582     390        881        (6,355     (5,666     (1,143     (597     (463     (5     (2,208

Loss on divestiture of operations

    —          —          —          —          —          (1,170     (356     (2,280     (939     (4,745
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from discontinued operations

    (582     390        881        (6,355     (5,666     (2,313     (953     (2,743     (944     (6,953
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

    22,097        (5,953     2,026        (71,889     (53,719     18,642        15,263        7,607        (80,836     (39,324

(Earnings) loss attributable to noncontrolling interests

    —          421        (241     58        238        (451     239        (41     (790     (1,043
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) attributable to Kindred

  $ 22,097      $ (5,532   $ 1,785      $ (71,831   $ (53,481   $ 18,191      $ 15,502      $ 7,566      $ (81,626   $ (40,367
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Amounts attributable to Kindred stockholders:

                   

Income (loss) from continuing operations

  $ 22,679      $ (5,922   $ 904      $ (65,476   $ (47,815   $ 20,504      $ 16,455      $ 10,309      $ (80,682   $ (33,414

Income (loss) from discontinued operations

    (582     390        881        (6,355     (5,666     (2,313     (953     (2,743     (944     (6,953
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 22,097      $ (5,532   $ 1,785      $ (71,831   $ (53,481   $ 18,191      $ 15,502      $ 7,566      $ (81,626   $ (40,367
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) per common share:

                   

Basic:

                   

Income (loss) from continuing operations

  $ 0.57      $ (0.14   $ 0.02      $ (1.28   $ (1.04   $ 0.39      $ 0.31      $ 0.19      $ (1.56   $ (0.65

Discontinued operations:

                   

Income (loss) from operations

    (0.01     0.01        0.01        (0.12     (0.12     (0.02     (0.01     (0.01     —          (0.04

Loss on divestiture of operations

    —          —          —          —          —          (0.02     (0.01     (0.04     (0.02     (0.09
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 0.56      $ (0.13   $ 0.03      $ (1.40   $ (1.16   $ 0.35      $ 0.29      $ 0.14      $ (1.58   $ (0.78
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted:

                   

Income (loss) from continuing operations

  $ 0.56      $ (0.14   $ 0.02      $ (1.28   $ (1.04   $ 0.39      $ 0.31      $ 0.19      $ (1.56   $ (0.65

Discontinued operations:

                   

Income (loss) from operations

    (0.01     0.01        0.01        (0.12     (0.12     (0.02     (0.01     (0.01     —          (0.04

Loss on divestiture of operations

    —          —          —          —          —          (0.02     (0.01     (0.04     (0.02     (0.09
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 0.55      $ (0.13   $ 0.03      $ (1.40   $ (1.16   $ 0.35      $ 0.29      $ 0.14      $ (1.58   $ (0.78
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing earnings (loss) per common share:

                   

Basic

    39,035        43,231        51,329        51,335        46,280        51,603        51,664        51,676        51,692        51,659   

Diluted

    39,543        43,231        51,406        51,335        46,280        51,638        51,675        51,709        51,692        51,659   

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 13

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Business Segment Data

(In thousands)

 

     2011 Quarters           2012 Quarters        
     First     Second     Third     Fourth     Year     First     Second     Third     Fourth     Year  

Revenues:

                    

Hospital division

   $ 556,244      $ 589,102      $ 678,714      $ 707,388      $ 2,531,448      $ 762,056      $ 726,717      $ 712,834      $ 725,888      $ 2,927,495   

Nursing center division

     567,472        568,199        571,226        547,202        2,254,099        544,319        535,644        534,188        533,989        2,148,140   

Rehabilitation division:

                    

Skilled nursing rehabilitation services

     114,618        161,246        252,574        246,720        775,158        255,451        255,187        253,459        246,004        1,010,101   

Hospital rehabilitation services

     22,490        38,291        69,811        70,232        200,824        74,369        73,379        71,899        73,885        293,532   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     137,108        199,537        322,385        316,952        975,982        329,820        328,566        325,358        319,889        1,303,633   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Home health and hospice division

     8,038        10,828        15,419        26,451        60,736        28,432        28,872        35,943        50,093        143,340   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     1,268,862        1,367,666        1,587,744        1,597,993        5,822,265        1,664,627        1,619,799        1,608,323        1,629,859        6,522,608   

Eliminations:

                    

Skilled nursing rehabilitation services

     (57,081     (57,587     (57,922     (57,087     (229,677     (58,433     (57,056     (55,534     (52,496     (223,519

Hospital rehabilitation services

     (21,065     (20,497     (20,359     (21,996     (83,917     (28,161     (27,646     (27,009     (27,694     (110,510

Nursing centers

     (865     (1,104     (1,299     (1,475     (4,743     (1,674     (1,862     (1,804     (1,948     (7,288
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (79,011     (79,188     (79,580     (80,558     (318,337     (88,268     (86,564     (84,347     (82,138     (341,317
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   $ 1,189,851      $ 1,288,478      $ 1,508,164      $ 1,517,435      $ 5,503,928      $ 1,576,359      $ 1,533,235      $ 1,523,976      $ 1,547,721      $ 6,181,291   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations:

                    

Operating income (loss):

                    

Hospital division

   $ 108,750      $ 108,543      $ 125,648      $ 145,260      $ 488,201      $ 162,273      $ 142,497      $ 139,350      $ 156,529 (a)    $ 600,649   

Nursing center division

     87,350        93,532        89,592        67,791        338,265        65,533        71,005        70,928        65,676 (a,b)      273,142   

Rehabilitation division:

                    

Skilled nursing rehabilitation services

     9,159        15,978        27,575        13,204        65,916        14,193        22,942        19,659        23,869 (a)      80,663   

Hospital rehabilitation services

     5,332        8,033        15,606        14,760        43,731        16,116        17,860        16,977        18,792 (a)      69,745   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     14,491        24,011        43,181        27,964        109,647        30,309        40,802        36,636        42,661        150,408   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Home health and hospice division

     (10     (447     1,107        2,453        3,103        2,341        2,789        3,645        4,933 (a)      13,708   

Corporate:

                    

Overhead

     (38,315     (43,801     (48,806     (43,878     (174,800     (42,728     (44,723     (45,883     (45,729 )(a)      (179,063

Insurance subsidiary

     (602     (420     (750     (534     (2,306     (482     (600     (545     (500     (2,127
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (38,917     (44,221     (49,556     (44,412     (177,106     (43,210     (45,323     (46,428     (46,229     (181,190

Impairment charges

     —          —          (26,712     (91,490     (118,202     (867     (329     (708     (108,952     (110,856

Transaction costs

     (4,179     (34,851     (6,537     (5,139     (50,706     (485     (597     (482     (667     (2,231
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     167,485        146,567        176,723        102,427        593,202        215,894        210,844        202,941        113,951        743,630   

Rent

     (91,216     (95,489     (105,205     (106,135     (398,045     (105,872     (107,053     (108,317     (107,737 )(c)      (428,979

Depreciation and amortization

     (32,496     (37,816     (46,814     (48,101     (165,227     (48,434     (49,742     (50,539     (52,353     (201,068

Interest, net

     (5,233     (22,900     (25,753     (26,002     (79,888     (26,286     (26,441     (26,439     (27,676     (106,842
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     38,540        (9,638     (1,049     (77,811     (49,958     35,302        27,608        17,646        (73,815     6,741   

Provision (benefit) for income taxes

     15,861        (3,295     (2,194     (12,277     (1,905     14,347        11,392        7,296        6,077        39,112   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   $ 22,679      $ (6,343   $ 1,145      $ (65,534   $ (48,053   $ 20,955      $ 16,216      $ 10,350      $ (79,892   $ (32,371
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Includes employee severance costs of $3.4 million (hospital division—$0.7 million, nursing center division—$1.9 million, rehabilitation division—$0.4 million, home health and hospice division—$0.2 million and corporate—$0.2 million) and contract cancellation costs of $0.9 million (corporate) incurred in connection with restructuring activities.
(b) Includes employee retention costs of $0.9 million incurred in connection with the decision to allow the leases to expire for 54 nursing centers leased from Ventas.
(c) Includes a lease cancellation charge of $0.1 million incurred in connection with restructuring activities.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 14

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Consolidating Statement of Operations

(In thousands)

 

    Fourth Quarter 2012  
          Nursing     Rehabilitation division     Home           Transaction-              
    Hospital     center     Skilled nursing     Hospital           health and           related              
    division (a,b)     division (a,c)     services (a)     services (a)     Total     hospice (a)     Corporate (a)     costs     Eliminations     Consolidated  

Revenues

  $ 725,888      $ 533,989      $ 246,004      $ 73,885      $ 319,889      $ 50,093      $ —        $ —        $  (82,138   $ 1,547,721   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    316,809        261,313        219,400        51,210        270,610        36,474        29,065        (100     —          914,171   

Supplies

    76,031        27,839        868        36        904        2,127        224        —          —          107,125   

Rent

    54,580        50,222        1,190        21        1,211        1,111        613        —          —          107,737   

Other operating expenses

    176,519        179,161        1,867        3,847        5,714        6,559        19,531        767        (82,138     306,113   

Other income

    —          —          —          —          —          —          (2,591     —          —          (2,591

Impairment charges

    118        935        107,899        —          107,899        —          —          —          —          108,952   

Depreciation and amortization

    23,574        14,014        2,918        2,334        5,252        1,482        8,031        —          —          52,353   

Interest expense

    206        20        120        —          120        (4     27,592        —          —          27,934   

Investment income

    (19     (30     (1     —          (1     —          (208     —          —          (258
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    647,818        533,474        334,261        57,448        391,709        47,749        82,257        667        (82,138     1,621,536   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

  $ 78,070      $ 515      $ (88,257   $ 16,437      $ (71,820   $ 2,344      $ (82,257   $ (667   $ —          (73,815
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Provision for income taxes

                      6,077   
                   

 

 

 

Loss from continuing operations

                    $ (79,892
                   

 

 

 

Capital expenditures, excluding acquisitions (including discontinued operations):

                   

Routine

  $ 9,817      $ 8,153      $ 672      $ 117      $ 789      $ 1,187      $ 18,425      $ —        $ —        $ 38,371   

Development

    6,693        5,454        —          —          —          —          —          —          —          12,147   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 16,510      $ 13,607      $ 672      $ 117      $ 789      $ 1,187      $ 18,425      $ —        $ —        $ 50,518   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    Fourth Quarter 2011  
          Nursing     Rehabilitation division     Home           Transaction-              
    Hospital     center     Skilled nursing     Hospital           health and           related              
    division (d)     division     services     services     Total     hospice     Corporate     costs     Eliminations     Consolidated  

Revenues

  $ 707,388      $ 547,202      $ 246,720      $ 70,232      $ 316,952      $ 26,451      $ —        $ —        $  (80,558   $ 1,517,435   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    318,093        269,454        221,404        50,151        271,555        19,155        28,976        647        (27     907,853   

Supplies

    76,407        28,450        843        67        910        1,025        251        —          —          107,043   

Rent

    51,818        49,748        1,415        72        1,487        568        695        1,819        —          106,135   

Other operating expenses

    167,628        181,507        11,269        5,254        16,523        3,818        17,896        4,492        (80,531     311,333   

Other income

    —          —          —          —          —          —          (2,711     —          —          (2,711

Impairment charges

    43,246        2,245        45,999        —          45,999        —          —          —          —          91,490   

Depreciation and amortization

    22,322        12,554        2,617        2,349        4,966        902        7,357        —          —          48,101   

Interest expense

    228        26        —          —          —          1        25,989        —          —          26,244   

Investment income

    (3     (28     —          —          —          (1     (210     —          —          (242
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    679,739        543,956        283,547        57,893        341,440        25,468        78,243        6,958        (80,558     1,595,246   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

  $ 27,649      $ 3,246      $ (36,827   $ 12,339      $ (24,488   $ 983      $ (78,243   $  (6,958   $ —          (77,811
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Income tax benefit

                      (12,277
                   

 

 

 

Loss from continuing operations

                    $ (65,534
                   

 

 

 

Capital expenditures, excluding acquisitions (including discontinued operations):

                   

Routine

  $ 9,521      $ 7,577      $ 1,031      $ 60      $ 1,091      $ 65      $ 19,386      $ —        $ —        $ 37,640   

Development

    13,157        4,027        —          —          —          901        —          —          —          18,085   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 22,678      $ 11,604      $ 1,031      $ 60      $ 1,091      $ 966      $ 19,386      $ —        $ —        $ 55,725   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Includes employee severance costs of $3.4 million (hospital division—$0.7 million, nursing center division—$1.9 million, rehabilitation division—$0.4 million, home health and hospice division—$0.2 million and corporate—$0.2 million) and contract cancellation costs of $0.9 million (corporate) incurred in connection with restructuring activities.
(b) Includes a lease cancellation charge of $0.1 million incurred in connection with restructuring activities.
(c) Includes employee retention costs of $0.9 million incurred in connection with the decision to allow the leases to expire for 54 nursing centers leased from Ventas.
(d) Includes loss on divestiture of a hospital of $1.5 million.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 15

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Consolidating Statement of Operations (Continued)

(In thousands)

 

    Year ended December 31, 2012  
          Nursing     Rehabilitation division     Home           Transaction-              
    Hospital     center     Skilled nursing     Hospital           health and           related              
    division (a,b)     division (a,c)     services (a)     services (a)     Total     hospice (a)     Corporate (a)     costs     Eliminations     Consolidated  

Revenues

  $ 2,927,495      $ 2,148,140      $ 1,010,101      $ 293,532      $ 1,303,633      $ 143,340      $ —        $ —        $ (341,317   $ 6,181,291   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    1,291,835        1,048,079        899,315        206,614        1,105,929        105,303        121,848        (450     (69     3,672,475   

Supplies

    314,230        107,766        3,093        163        3,256        5,953        803        —          —          432,008   

Rent

    217,341        200,679        5,250        140        5,390        3,140        2,429        —          —          428,979   

Other operating expenses

    720,781        719,153        27,030        17,010        44,040        18,376        69,351        2,681        (341,248     1,233,134   

Other income

    —          —          —          —          —          —          (10,812     —          —          (10,812

Impairment charges

    753        2,204        107,899        —          107,899        —          —          —          —          110,856   

Depreciation and amortization

    91,776        53,548        11,061        9,309        20,370        4,442        30,932        —          —          201,068   

Interest expense

    1,016        88        156        —          156        —          106,636        —          —          107,896   

Investment income

    (79     (98     (2     —          (2     —          (875     —          —          (1,054
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2,637,653        2,131,419        1,053,802        233,236        1,287,038        137,214        320,312        2,231        (341,317     6,174,550   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

  $ 289,842      $ 16,721      $ (43,701   $ 60,296      $ 16,595      $ 6,126      $ (320,312   $ (2,231   $ —          6,741   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Provision for income taxes

                      39,112   
                   

 

 

 

Loss from continuing operations

                    $ (32,371
                   

 

 

 

Capital expenditures, excluding acquisitions (including discontinued operations):

                   

Routine

  $ 38,272      $ 20,764      $ 2,274      $ 348      $ 2,622      $ 1,616      $ 51,901      $ —        $ —        $ 115,175   

Development

    42,265        8,057        —          —          —          —          —          —          —          50,322   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 80,537      $ 28,821      $ 2,274      $ 348      $ 2,622      $ 1,616      $ 51,901      $ —        $ —        $ 165,497   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    Year ended December 31, 2011  
          Nursing     Rehabilitation division     Home           Transaction-              
    Hospital     center     Skilled nursing     Hospital           health and           related              
    division(d)     division     services     services     Total     hospice     Corporate     costs     Eliminations     Consolidated  

Revenues

  $ 2,531,448      $ 2,254,099      $ 775,158      $ 200,824      $ 975,982      $ 60,736      $ —        $ —        $ (318,337   $ 5,503,928   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    1,152,274        1,085,476        679,177        144,147        823,324        45,378        120,478        16,769        (96     3,243,603   

Supplies

    281,433        112,095        2,826        189        3,015        2,438        838        —          —          399,819   

Rent

    188,120        198,556        6,275        228        6,503        1,366        1,681        1,819        —          398,045   

Other operating expenses

    609,540        718,263        27,239        12,757        39,996        9,817        66,981        33,937        (318,241     1,160,293   

Other income

    —          —          —          —          —          —          (11,191     —          —          (11,191

Impairment charges

    46,348        25,855        45,999        —          45,999        —          —          —          —          118,202   

Depreciation and amortization

    74,543        50,040        7,191        5,637        12,828        1,449        26,367        —          —          165,227   

Interest expense

    500        102        —          —          —          1        66,514        13,802        —          80,919   

Investment income

    (7     (86     (3     (1     (4     (1     (933     —          —          (1,031
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2,352,751        2,190,301        768,704        162,957        931,661        60,448        270,735        66,327        (318,337     5,553,886   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

  $ 178,697      $ 63,798      $ 6,454      $ 37,867      $ 44,321      $ 288      $ (270,735   $ (66,327   $ —          (49,958
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Income tax benefit

                      (1,905
                   

 

 

 

Loss from continuing operations

                    $ (48,053
                   

 

 

 

Capital expenditures, excluding acquisitions (including discontinued operations):

                   

Routine

  $ 46,393      $ 34,304      $ 1,700      $ 238      $ 1,938      $ 164      $ 50,104      $ —        $ —        $ 132,903   

Development

    67,321        19,167        —          —          —          1,167        —          —          —          87,655   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 113,714      $ 53,471      $ 1,700      $ 238      $ 1,938      $ 1,331      $ 50,104      $ —        $ —        $ 220,558   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Includes employee severance costs of $3.4 million (hospital division—$0.7 million, nursing center division—$1.9 million, rehabilitation division—$0.4 million, home health and hospice division—$0.2 million and corporate—$0.2 million) and contract cancellation costs of $0.9 million (corporate) incurred in connection with restructuring activities.
(b) Includes severance costs ($2.5 million), restructuring costs ($2.0 million) and lease cancellation charges ($1.6 million) incurred in connection with the closing of a regional office, the closing of two TC hospitals and the cancellation of a sub-acute unit project, and $5.0 million for employment-related lawsuits.
(c) Includes employee retention costs of $2.2 million incurred in connection with the decision to allow the leases to expire for 54 nursing centers leased from Ventas.
(d) Includes loss on divestiture of a hospital of $1.5 million.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 16

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Business Segment Data

(Unaudited)

 

     2011 Quarters             2012 Quarters         
     First      Second      Third      Fourth      Year      First      Second      Third      Fourth      Year  

Hospital division data:

                             

End of period data:

                             

Number of hospitals:

                             

Transitional care

     88         117         117         118            118         117         116         116      

Inpatient rehabilitation

     —           5         5         5            6         6         6         6      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    
     88         122         122         123            124         123         122         122      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    

Number of licensed beds:

                             

Transitional care

     6,779         8,443         8,431         8,431            8,454         8,404         8,347         8,382      

Inpatient rehabilitation

     —           183         183         183            229         259         259         259      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    
     6,779         8,626         8,614         8,614            8,683         8,663         8,606         8,641      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    

Revenue mix %:

                             

Medicare

     60         60         60         62         60         62         61         61         62         62   

Medicaid

     8         8         7         7         8         6         6         6         6         6   

Medicare Advantage

     10         10         10         10         10         10         11         11         10         10   

Commercial insurance and other

     22         22         23         21         22         22         22         22         22         22   

Admissions:

                             

Medicare

     8,451         8,829         10,884         11,560         39,724         12,312         11,485         11,244         11,372         46,413   

Medicaid

     1,073         1,130         1,205         1,127         4,535         1,010         1,032         1,025         957         4,024   

Medicare Advantage

     1,172         1,326         1,598         1,529         5,625         1,770         1,955         1,794         1,744         7,263   

Commercial insurance and other

     2,266         2,250         2,648         2,821         9,985         3,058         2,762         2,792         2,704         11,316   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     12,962         13,535         16,335         17,037         59,869         18,150         17,234         16,855         16,777         69,016   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Admissions mix %:

                             

Medicare

     65         65         67         68         66         68         67         67         68         67   

Medicaid

     8         8         7         7         8         5         6         6         6         6   

Medicare Advantage

     9         10         10         9         9         10         11         11         10         11   

Commercial insurance and other

     18         17         16         16         17         17         16         16         16         16   

Patient days:

                             

Medicare

     218,164         235,567         272,091         282,293         1,008,115         302,761         288,696         280,855         284,824         1,157,136   

Medicaid

     44,528         44,351         47,768         47,568         184,215         44,748         43,088         46,307         44,504         178,647   

Medicare Advantage

     35,623         39,152         46,945         47,163         168,883         50,551         53,293         51,738         49,660         205,242   

Commercial insurance and other

     70,129         72,034         83,013         84,162         309,338         88,693         85,424         85,513         83,087         342,717   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     368,444         391,104         449,817         461,186         1,670,551         486,753         470,501         464,413         462,075         1,883,742   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Average length of stay:

                             

Medicare

     25.8         26.7         25.0         24.4         25.4         24.6         25.1         25.0         25.0         24.9   

Medicaid

     41.5         39.2         39.6         42.2         40.6         44.3         41.8         45.2         46.5         44.4   

Medicare Advantage

     30.4         29.5         29.4         30.8         30.0         28.6         27.3         28.8         28.5         28.3   

Commercial insurance and other

     30.9         32.0         31.3         29.8         31.0         29.0         30.9         30.6         30.7         30.3   

Weighted average

     28.4         28.9         27.5         27.1         27.9         26.8         27.3         27.6         27.5         27.3   

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 17

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

 

     2011 Quarters             2012 Quarters         
     First      Second      Third      Fourth      Year      First      Second      Third      Fourth      Year  

Hospital division data (continued):

                             

Revenues per admission:

                             

Medicare

   $ 39,505       $ 40,246       $ 37,449       $ 37,739       $ 38,592       $ 38,597       $ 38,761       $ 38,434       $ 39,689       $ 38,866   

Medicaid

     42,342         41,699         41,087         45,382         42,604         46,380         44,774         45,536         46,241         45,720   

Medicare Advantage

     46,180         43,108         43,263         46,278         44,654         42,478         39,449         42,671         42,625         41,746   

Commercial insurance and other

     54,207         57,551         57,582         52,896         55,485         53,899         57,283         56,395         57,674         56,243   

Weighted average

     42,913         43,524         41,550         41,521         42,283         41,987         42,168         42,292         43,267         42,418   

Revenues per patient day:

                             

Medicare

   $ 1,530       $ 1,508       $ 1,498       $ 1,545       $ 1,521       $ 1,570       $ 1,542       $ 1,539       $ 1,585       $ 1,559   

Medicaid

     1,020         1,062         1,036         1,075         1,049         1,047         1,072         1,008         994         1,030   

Medicare Advantage

     1,519         1,460         1,473         1,500         1,487         1,487         1,447         1,480         1,497         1,477   

Commercial insurance and other

     1,752         1,798         1,837         1,773         1,791         1,858         1,852         1,841         1,877         1,857   

Weighted average

     1,510         1,506         1,509         1,534         1,515         1,565         1,545         1,535         1,571         1,554   

Medicare case mix index (discharged patients only)

     1.21         1.22         1.17         1.14         1.18         1.18         1.17         1.15         1.14         1.16   

Average daily census

     4,094         4,298         4,889         5,013         4,577         5,349         5,170         5,048         5,023         5,147   

Occupancy %

     68.9         65.6         62.7         63.7         65.0         67.7         64.9         64.0         63.6         65.0   

Annualized employee turnover %

     21.2         22.1         21.4         20.3            21.8         22.2         21.1         20.1      

Nursing center division data:

                             

End of period data:

                             

Number of facilities:

                             

Nursing centers:

                             

Owned or leased

     220         220         220         220            220         220         220         219      

Managed

     4         4         4         4            4         4         4         4      

Assisted living facilities

     6         6         6         6            6         6         6         6      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    
     230         230         230         230            230         230         230         229      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    

Number of licensed beds:

                             

Nursing centers:

                             

Owned or leased

     26,767         26,687         26,687         26,663            26,663         26,711         26,711         26,657      

Managed

     485         485         485         485            485         485         485         485      

Assisted living facilities

     413         413         413         413            413         341         341         341      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    
     27,665         27,585         27,585         27,561            27,561         27,537         27,537         27,483      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    

Revenue mix %:

                             

Medicare

     38         37         36         33         36         34         33         32         32         33   

Medicaid

     37         38         38         40         38         39         41         41         41         41   

Medicare Advantage

     7         7         7         7         7         8         7         7         7         7   

Private and other

     18         18         19         20         19         19         19         20         20         19   

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 18

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

 

     2011 Quarters             2012 Quarters         
     First      Second      Third      Fourth      Year      First      Second      Third      Fourth      Year  

Nursing center division data (continued):

                             

Patient days (a):

                             

Medicare

     370,395         358,760         345,362         334,156         1,408,673         342,567         328,011         313,642         312,728         1,296,948   

Medicaid

     1,232,620         1,229,517         1,255,418         1,248,442         4,965,997         1,218,903         1,215,623         1,226,855         1,218,616         4,879,997   

Medicare Advantage

     97,460         94,483         95,751         95,730         383,424         101,312         97,583         93,287         90,187         382,369   

Private and other

     425,414         435,667         436,074         441,362         1,738,517         422,983         412,403         423,070         419,346         1,677,802   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     2,125,889         2,118,427         2,132,605         2,119,690         8,496,611         2,085,765         2,053,620         2,056,854         2,040,877         8,237,116   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Patient day mix % (a):

                             

Medicare

     17         17         16         16         17         16         16         15         15         16   

Medicaid

     58         58         59         59         58         59         59         60         60         59   

Medicare Advantage

     5         4         5         4         5         5         5         4         4         5   

Private and other

     20         21         20         21         20         20         20         21         21         20   

Revenues per patient day (a):

                             

Medicare Part A

   $ 537       $ 544       $ 550       $ 491       $ 531       $ 484       $ 483       $ 490       $ 504       $ 490   

Total Medicare (including Part B)

     579         589         599         544         578         536         538         546         548         542   

Medicaid

     172         173         174         176         174         176         178         179         181         179   

Medicaid (net of provider taxes) (b)

     155         156         155         156         156         156         158         158         160         158   

Medicare Advantage

     416         420         421         405         415         407         405         409         409         407   

Private and other

     235         240         243         241         240         248         250         250         251         249   

Weighted average

     267         268         268         258         265         261         261         260         262         261   

Average daily census (a)

     23,621         23,279         23,180         23,040         23,278         22,920         22,567         22,357         22,183         22,506   

Admissions (a)

     20,619         20,143         20,118         19,914         80,794         20,863         19,593         19,064         19,412         78,932   

Occupancy % (a)

     86.9         85.9         85.5         85.1         85.9         84.7         83.5         82.6         82.1         83.2   

Medicare average length of stay (a)

     32.9         33.4         33.0         32.1         32.8         31.8         32.2         32.8         31.3         32.0   

Annualized employee turnover %

     37.8         39.8         40.2         39.2            36.9         39.2         39.9         39.6      

Rehabilitation division data:

                             

Skilled nursing rehabilitation services:

                             

Revenue mix %:

                             

Company-operated

     50         36         23         23         30         23         22         22         21         22   

Non-affiliated

     50         64         77         77         70         77         78         78         79         78   

Sites of service (at end of period)

     641         1,848         1,835         1,774            1,722         1,730         1,735         1,726      

Revenue per site

   $ 178,812       $ 137,316       $ 137,643       $ 139,077       $ 592,848       $ 148,346       $ 147,507       $ 146,086       $ 142,529       $ 584,468   

Therapist productivity %

     80.6         81.6         80.5         80.1         80.4         80.3         80.4         80.5         80.5         80.4   

Hospital rehabilitation services:

                             

Revenue mix %:

                             

Company-operated

     94         54         29         31         42         38         38         38         37         38   

Non-affiliated

     6         46         71         69         58         62         62         62         63         62   

Sites of service (at end of period):

                             

Inpatient rehabilitation units

     1         104         102         102            100         102         104         105      

LTAC hospitals

     93         97         99         115            125         125         123         123      

Sub-acute units

     8         22         23         25            19         20         20         21      

Outpatient units

     12         119         114         115            111         115         117         119      

Other

     5         8         7         8            5         5         5         5      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    
     119         350         345         365            360         367         369         373      
  

 

 

    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

    

 

 

    

 

 

    

Revenue per site

   $ 188,989       $ 199,661       $ 202,352       $ 192,410       $ 783,412       $ 206,580       $ 199,943       $ 194,848       $ 198,083       $ 799,454   

Annualized employee turnover %

     14.5         17.1         16.5         16.5            19.6         16.9         17.3         16.9      

 

(a) Excludes managed facilities.
(b) Provider taxes are recorded in other operating expenses for all periods presented.

 

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 19

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Earnings Per Common Share Reconciliation (a)

(In thousands, except per share amounts)

 

    Three months ended December 31,     Year ended December 31,  
    2012     2011     2012     2011  
    Basic     Diluted     Basic     Diluted     Basic     Diluted     Basic     Diluted  

Loss:

               

Amounts attributable to Kindred stockholders:

               

Loss from continuing operations:

               

As reported in Statement of Operations

  $ (80,682   $ (80,682   $ (65,476   $ (65,476   $ (33,414   $ (33,414   $ (47,815   $ (47,815

Allocation to participating unvested restricted stockholders

    —          —          —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ (80,682   $ (80,682   $ (65,476   $ (65,476   $ (33,414   $ (33,414   $ (47,815   $ (47,815
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Discontinued operations, net of income taxes:

               

Loss from operations:

               

As reported in Statement of Operations

  $ (5   $ (5   $ (6,355   $ (6,355   $ (2,208   $ (2,208   $ (5,666   $ (5,666

Allocation to participating unvested restricted stockholders

    —          —          —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ (5   $ (5   $ (6,355   $ (6,355   $ (2,208   $ (2,208   $ (5,666   $ (5,666
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss on divestiture of operations:

               

As reported in Statement of Operations

  $ (939   $ (939   $ —        $ —        $ (4,745   $ (4,745   $ —        $ —     

Allocation to participating unvested restricted stockholders

    —          —          —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ (939   $ (939   $ —        $ —        $ (4,745   $ (4,745   $ —        $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss:

               

As reported in Statement of Operations

  $ (81,626   $ (81,626   $ (71,831   $ (71,831   $ (40,367   $ (40,367   $ (53,481   $ (53,481

Allocation to participating unvested restricted stockholders

    —          —          —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ (81,626   $ (81,626   $ (71,831   $ (71,831   $ (40,367   $ (40,367   $ (53,481   $ (53,481
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in the computation:

               

Weighted average shares outstanding—basic computation

    51,692        51,692        51,335        51,335        51,659        51,659        46,280        46,280   
 

 

 

     

 

 

     

 

 

     

 

 

   

Dilutive effect of employee stock options

      —            —            —            —     

Dilutive effect of performance-based restricted shares

      —            —            —            —     
   

 

 

     

 

 

     

 

 

     

 

 

 

Adjusted weighted average shares outstanding—diluted computation

      51,692          51,335          51,659          46,280   
   

 

 

     

 

 

     

 

 

     

 

 

 

Loss per common share:

               

Loss from continuing operations

  $ (1.56   $ (1.56   $ (1.28   $ (1.28   $ (0.65   $ (0.65   $ (1.04   $ (1.04

Discontinued operations:

               

Loss from operations

    —          —          (0.12     (0.12     (0.04     (0.04     (0.12     (0.12

Loss on divestiture of operations

    (0.02     (0.02     —          —          (0.09     (0.09     —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

  $ (1.58   $ (1.58   $ (1.40   $ (1.40   $ (0.78   $ (0.78   $ (1.16   $ (1.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Loss per common share is based upon the weighted average number of common shares outstanding during the respective periods. The Company follows the provisions of the authoritative guidance for determining whether instruments granted in share-based payment transactions are participating securities, which requires that certain unvested restricted stock be included as a participating security in the basic and diluted earnings per common share calculation pursuant to the two-class method. However, because the Company reported a loss from continuing operations, there was no allocation to participating unvested restricted stockholders for all periods presented.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 20

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results

(Unaudited)

(In thousands, except per share amounts and statistics)

In addition to the results provided in accordance with GAAP, the Company has provided information in this release to compute certain non-GAAP measurements for the fourth quarters and years ended December 31, 2012 and 2011 before certain charges or on a core basis. The charges that were excluded from core operating results are denoted in the table below.

The income tax benefit associated with the excluded charges was calculated using an effective income tax rate of 7.5% and 10.7% for the fourth quarter and year ended December 31, 2012, respectively, and an effective income tax rate of 20.0% and 27.8% for the fourth quarter and year ended December 31, 2011, respectively. Certain of the excluded charges for the fourth quarter and year ended December 31, 2012 are not deductible for income tax purposes thus resulting in a lower effective income tax rate than the comparable prior year periods.

The use of these non-GAAP measurements are not intended to replace the presentation of the Company’s financial results in accordance with GAAP. The Company believes that the presentation of core operating results provides additional information to investors to facilitate the comparison between periods by excluding certain charges for the fourth quarters and years ended December 31, 2012 and 2011 that the Company believes are not representative of its ongoing operations due to the materiality and nature of the charges. The Company’s core operating results also represent a key performance measure for the purpose of evaluating performance internally.

 

     Three months ended
December 31,
    Year ended
December 31,
 
     2012     2011     2012     2011  

Detail of charges:

        

Severance, employee retention and restructuring costs

     ($4,938     ($647     ($10,424     ($16,769

Lease cancellation charges (included in rent expense)

     (176     (1,819     (1,691     (1,819

Employment-related lawsuits

     —          —          (5,000     —     

Transaction costs

     (767     (4,492     (2,681     (33,937

Impairment charges

     (107,899     (91,490     (107,899     (118,202

Loss on hospital divestiture

     —          (1,490     —          (1,490

Financing costs (in connection with RehabCare acquisition)

     —          —          —          (13,802
  

 

 

   

 

 

   

 

 

   

 

 

 
     (113,780     (99,938     (127,695     (186,019

Income tax benefit

     8,507        20,020        13,636        51,728   
  

 

 

   

 

 

   

 

 

   

 

 

 

Charges net of income taxes

     (105,273     (79,918     (114,059     (134,291

Allocation to participating unvested restricted stockholders

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

     ($105,273     ($79,918     ($114,059     ($134,291
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares outstanding

     51,692        51,335        51,659        46,280   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted loss per common share related to charges

     ($2.04     ($1.56     ($2.21     ($2.90
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of operating income before charges:

        

Operating income before charges

   $ 227,555      $ 200,546      $ 869,634      $ 763,600   

Detail of charges excluded from core operating results:

        

Severance, employee retention and restructuring costs

     (4,938     (647     (10,424     (16,769

Employment-related lawsuits

     —          —          (5,000     —     

Transaction costs

     (767     (4,492     (2,681     (33,937

Impairment charges

     (107,899     (91,490     (107,899     (118,202

Loss on hospital divestiture

     —          (1,490     —          (1,490
  

 

 

   

 

 

   

 

 

   

 

 

 
     (113,604     (98,119     (126,004     (170,398
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported operating income

   $ 113,951      $ 102,427      $ 743,630      $ 593,202   
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of income from continuing operations before charges:

        

Amounts attributable to Kindred stockholders:

        

Income from continuing operations before charges

   $ 24,591      $ 14,442      $ 80,645      $ 86,476   

Charges net of income taxes

     (105,273     (79,918     (114,059     (134,291
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported loss from continuing operations

     ($80,682     ($65,476     ($33,414     ($47,815
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of diluted income per common share from continuing operations before charges:

        

Diluted income per common share before charges (a)

   $ 0.46      $ 0.28      $ 1.52      $ 1.83   

Charges net of income taxes

     (2.04     (1.56     (2.21     (2.90

Other

     0.02        —          0.04        0.03   
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported diluted loss per common share from continuing operations

     ($1.56     ($1.28     ($0.65     ($1.04
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares used to compute diluted income per common share from continuing operations before charges

     51,984        51,371        51,815        46,587   

Reconciliation of effective income tax rate before charges:

        

Effective income tax rate before charges

     36.5     35.0     39.2     36.6

Impact of charges on effective income tax rate

     -28.3     -19.2     541.0     -32.8
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported effective income tax rate

     8.2     15.8     580.2     3.8
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) For purposes of computing diluted earnings per common share before charges, income from continuing operations before charges was reduced by $0.7 million and $0.2 million for the fourth quarters ended December 31, 2012 and 2011, respectively, and $1.9 million and $1.4 million for the years ended December 31, 2012 and 2011, respectively, for the allocation of income to participating unvested restricted stockholders.

 

- MORE -


Kindred Healthcare Announces Fourth Quarter Results

Page 21

February 25, 2013

 

KINDRED HEALTHCARE, INC.

Reconciliation of Earnings Guidance for 2013—Continuing Operations (a)

(Unaudited)

(In millions, except per share amounts)

 

     As of February 25, 2013     As of January 7, 2013  
     Low     High     Low     High  

Operating income

   $ 794      $ 810      $ 794      $ 810   
  

 

 

   

 

 

   

 

 

   

 

 

 

Rent

     387        387        387        387   

Depreciation and amortization

     189        189        189        189   

Interest, net

     113        113        113        113   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     105        121        105        121   

Provision for income taxes

     44        50        44        50   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     61        71        61        71   

Earnings attributable to noncontrolling interests

     (1     (1     (1     (1
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations attributable to the Company

     60        70        60        70   

Allocation to participating unvested restricted stockholders

     (2     (2     (2     (2
  

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

   $ 58      $ 68      $ 58      $ 68   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per diluted share

   $ 1.10      $ 1.30      $ 1.10      $ 1.30   

Shares used in computing earnings per diluted share

     52.7        52.7        52.7        52.7   

 

(a) The Company’s earnings guidance assumes (a) reductions in Medicare payments for rehabilitation therapy services, including those contained in the Taxpayer Relief Act, expected to range from $25 million to $30 million on an annual basis, and (b) sequestration cuts of 2% related to all of its Medicare revenues that will begin on April 1, 2013. In addition, the earnings guidance assumes that the previously announced exit in 2013 from 54 nursing centers leased from Ventas will be reflected as discontinued operations effective January 1, 2013. The earnings guidance also excludes the effect of any other reimbursement changes, any future acquisitions or dispositions, any impairment charges, any repurchases of common stock and an expected $25 million one-time bonus to be paid to approximately 47,000 employees who do not participate in the Company’s incentive compensation program.

 

- END -